The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 211.00
Bid: 209.00
Ask: 209.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.239%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 211.00
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

16 Sep 2019 16:13

RNS Number : 5023M
TP ICAP PLC
16 September 2019
 

16 September 2019

 

TP ICAP acquires ClearCompress

Expansion into innovative compression services

 

TP ICAP plc ("TP ICAP" or "the Company") today announces that it has acquired ClearCompress Limited ("ClearCompress"), a provider of innovative, algorithm-based, light-touch compression services in cleared and uncleared derivatives that assist clients to achieve cost efficiencies and capital reduction.

 

TP ICAP and ClearCompress started collaborating in 2017. At that time, ClearCompress contributed development and algorithm expertise and TP ICAP contributed access to clients and support infrastructure. The parties deepened their relationship in March 2019 when TP ICAP agreed to provide funding of £500,000 and the benefit of its regulated status to ClearCompress. The parties have now agreed to formalise their relationship with the acquisition of ClearCompress by TP ICAP. The key team members of ClearCompress, including David Hill, the CEO, will remain with the business and continue to expand its client base and service range.

 

The sellers of ClearCompress are the founders, early-stage investors and management team. The consideration for the acquisition is £750,000 in cash to be paid over 2 years, and performance-related payments for the 6 years starting 1 September 2019 until 31 August 2025 based on the revenues of the business, payable annually in cash or shares at the discretion of TP ICAP.

 

The gross assets of ClearCompress at 31 January 2019 were £88,152 and the business reported a loss before tax of £346,606 for the year ended 31 January 2019.

 

Nicolas Breteau, CEO of TP ICAP, said, "The acquisition of ClearCompress is in line with our strategy to broaden our customer service offering. The compression runs we have conducted demonstrate excellent outcomes for our clients. We are delighted to welcome this innovative company with its expertise in algo-driven capital optimisation solutions to our group and we are excited to move forward and grow the business together."

 

David Hill, CEO of ClearCompress, said, "As ClearCompress enters the next phase in its development, we are looking forward to being a part of the TP ICAP Group which will enable us to accelerate our client reach, develop new products and expand internationally. Our partnership with TP ICAP and the solutions we deliver have been well received by clients and we are enthusiastic and confident about what more we can do in the future."

 

ENDS

 

Enquiries:

 

TP ICAP:

Analysts and Investors

Al Alevizakos

Alevizos.Alevizakos@tpicap.com

+44 (0) 203 933 3040

 

Media

William Baldwin-Charles

William.Baldwin-Charles@tpicap.com 

+44 (0) 20 7200 7124

 

About TPICAP

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQCKADDPBKDBCD
Date   Source Headline
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman
15th May 20194:37 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement and Trading Update
12th Apr 20191:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:35 pmRNSDirector/PDMR Shareholding
19th Mar 20197:01 amRNSConfirmation of Director Appointment
19th Mar 20197:00 amRNSFinal Results
1st Mar 20192:58 pmRNSHolding(s) in Company
28th Feb 20192:22 pmRNSHolding(s) in Company
21st Feb 20194:14 pmRNSHolding(s) in Company
7th Feb 20194:15 pmRNSHolding(s) in Company
29th Jan 20192:13 pmRNSStatement re Press Release
28th Jan 20195:00 pmRNSHolding(s) in Company
25th Jan 20197:00 amRNSBoard Committee Changes
17th Jan 20199:17 amRNSHolding(s) in Company
14th Dec 20181:52 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSDirectorate Change
13th Dec 20189:22 amRNSHolding(s) in Company
4th Dec 20184:15 pmRNSHolding(s) in Company
3rd Dec 20183:59 pmRNSHolding(s) in Company
16th Nov 20184:08 pmRNSHolding(s) in Company
16th Nov 20183:42 pmRNSDirector Declaration
14th Nov 201812:19 pmRNSHolding(s) in Company
14th Nov 201811:03 amRNSDirector/PDMR Shareholding
13th Nov 20183:52 pmRNSDirector/PDMR Shareholding
9th Nov 20183:29 pmRNSHolding(s) in Company
7th Nov 201812:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20183:23 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSTrading Statement
2nd Nov 20187:00 amRNSAcquisition
25th Oct 201810:06 amRNSHolding(s) in Company
2nd Oct 20184:24 pmRNSDirector/PDMR PCA Share Acquisition
25th Sep 20184:35 pmRNSDirector/PDMR Shareholding
25th Sep 20184:34 pmRNSDirector/PDMR Shareholding
18th Sep 20183:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.